Skip to main content

Table 1 Characteristics of the subjects in the study

From: Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves’ disease

Group n Gender
M/F
Age TRAb
(IU/L)
TPOAb
(IU/L)
TSH
(mIU/L)
FT3
(pg/ml)
FT4
(ng/dl)
Methimazole
(mg)
GD 52 18/34 36.46 ± 11.53 11.98 ± 20.53 179.18 ± 253.26 0.16 ± 0.41 6.17 ± 4.97 1.88 ± 1.35 14.71 ± 8.37
HT 39 12/27 37.89 ± 15.59  N.A. 221.62 ± 317.05 5.55 ± 9.80 3.2 0 ± 0.67 0.86 ± 0.17  N.A.
HC 23 12/11 39.96 ± 12.14 < 1.75 < 3.5  N.A. N.A. N.A. N.A.
  1. TRAb thyrotropin receptor autoantibody; TPOAb thyroid peroxidase autoantibody; TSH thyroid stimulating hormone; FT3 free triiodothyronine; FT4 free thyroxine; GD Graves’ disease; HT Hashimoto’s thyroiditis; FT4 free thyroxine